THE USMLE TIMES - #82
Highlights for the week of July 1, 2024
Welcome to issue #82 of The USMLE Times… We’ve now posted our USMLE newsletter eighty-two weeks in a row! Welcome to the 159 new members of the community 👋
Here’s what’s on tap for issue #82 of the USMLE Times:
Question of the Week (Cardiovascular medicine)
This week’s video training (250+ on Step 2 CK - 5 TIPS)
Tweet thread of the week
Links to recent training
Question deep-dive & breakdown
Let’s dive in!
A 65-year-old male with a history of hypertension, type 2 diabetes mellitus, and a 20-pack-year smoking history presents to the emergency department with a 3-hour history of severe, crushing chest pain that began at rest and radiates to his left arm. He is diaphoretic, anxious, and nauseous. His vital signs are temperature 37°C (98.6°F), blood pressure 145/85 mmHg, pulse 110/minute, respiratory rate 20/minute, and oxygen saturation 95% on room air. An ECG reveals 1.5 mm ST-segment elevations in leads II, III, and aVF with reciprocal ST-segment depressions in leads I, aVL, and V2-V4. His cardiac troponin T level is 0.5 ng/mL (normal: <0.01 ng/mL). He is administered aspirin, sublingual nitroglycerin, and supplemental oxygen. Given his clinical presentation, which of the following is the most appropriate next step in management?
A. Administer a beta-blocker, nitroglycerin infusion, and intravenous heparin
B. Administer an angiotensin-converting enzyme (ACE) inhibitor and a statin
C. Immediate percutaneous coronary intervention (PCI)
D. Administer a calcium channel blocker and an angiotensin II receptor blocker (ARB)
E. Thrombolytic therapy with intravenous tissue plasminogen activator (tPA)
The answer & question breakdown is at the bottom of the post.
📺 USMLE TRAINING 👇
💬 THIS WEEK’S TWITTER THREAD
READ THE FULL THREAD HERE.
Click HERE To Follow Us On Twitter/X
🔗 LINKS TO RECENT POSTS
The King of Bulls**it USMLE Qbank Advice - READ HERE
USMLE Times Issue #81 - READ HERE
Building an AI USMLE Study Partner - READ HERE
USMLE Times Issue #80 - READ HERE
Should I Take Step 3 Before Match? - READ HERE
USMLE Times Issue #79 - READ HERE
Suffering From Premature P.O.E.? - READ HERE
ANSWER + QUESTION BREAKDOWN
The Mental Model for this week’s question:
Step 1. Identify the goal of the question (Next step in mgmt).
Step 2. Identify the problem.
Step 3. Outline the steps in mgmt (in your head).
Step 4. Ask yourself the next best step (in your head).
Step 5. Look for your derived answer in the options.
GENERAL ANALYSIS
This patient presents with classic symptoms of acute myocardial infarction (MI), specifically an ST-elevation myocardial infarction (STEMI), as evidenced by the ECG findings of ST-segment elevations in the inferior leads (II, III, aVF) and reciprocal depressions in the lateral and anterior leads (I, aVL, V2-V4). The elevated cardiac troponin T level further supports the diagnosis of an acute MI. The immediate goal in managing STEMI is to restore coronary blood flow as quickly as possible to minimize myocardial damage.
ANSWER CHOICES:
ANSWER CHOICE A: Administer a beta-blocker, nitroglycerin infusion, and intravenous heparin
• Beta-blockers: While beta-blockers are beneficial in reducing myocardial oxygen demand, they are not the first-line treatment in the acute setting of STEMI due to the risk of cardiogenic shock, especially if the patient is hemodynamically unstable.
• Nitroglycerin infusion: This can help alleviate chest pain and reduce myocardial oxygen demand but is not the definitive treatment for STEMI.
• Intravenous heparin: Anticoagulation is important but is typically used with reperfusion therapy, not as a standalone treatment.
ANSWER CHOICE B: Administer an angiotensin-converting enzyme (ACE) inhibitor and a statin
• ACE inhibitors: These are beneficial in the long-term management of MI, particularly in patients with heart failure or reduced ejection fraction, but they are not the immediate treatment of choice in the acute setting.
• Statins: These are important for secondary prevention but do not address the immediate need for reperfusion in an acute STEMI.
ANSWER CHOICE C: Immediate percutaneous coronary intervention (PCI)
• PCI: This can directly address the underlying cause of the MI by mechanically opening the blocked coronary artery, thereby restoring blood flow and minimizing myocardial damage.
ANSWER CHOICE D: Administer a calcium channel blocker and an angiotensin II receptor blocker (ARB)
• Calcium channel blockers: These are not typically used in the acute management of STEMI due to their potential to exacerbate heart failure and hypotension.
• ARBs: Similar to ACE inhibitors, ARBs are used for long-term management but are not the immediate treatment of choice in the acute setting.
ANSWER CHOICE E: Thrombolytic therapy with intravenous tissue plasminogen activator (tPA)
• Thrombolytic therapy: This is an alternative to PCI when PCI is unavailable within the recommended time frame. Thrombolytics can dissolve the clot causing the MI, but they are generally considered less effective than PCI and carry a higher risk of bleeding.
FINAL VERDICT…
Immediate PCI is the most appropriate next step in managing this patient with STEMI and is the gold standard treatment option if performed within 90 minutes of first medical contact. PCI is preferred over thrombolytic therapy because it has been shown to be more effective in restoring coronary blood flow, reducing infarct size, and improving survival rates. The goal of performing PCI within 90 minutes of first medical contact is feasible in many healthcare settings with the necessary facilities. PCI involves mechanically opening the blocked coronary artery using a balloon and often placing a stent to keep the artery open, restoring blood flow to the affected myocardial tissue.
FINAL ANSWER: C: Immediate percutaneous coronary intervention (PCI)
That’s it for issue #82 of The USMLE Times!
Don’t forget that Sharing is Caring!
If you enjoyed and found this week’s edition of The USMLE Times helpful, please consider sharing it with someone you think will enjoy it.
Thanks for tuning in… See you next time 👋
